Cooper Companies, Inc. (The) (NYSE:COO) Director Gary S. Petersmeyer sold 3,977 shares of the company’s stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $244.94, for a total transaction of $974,126.38. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Gary S. Petersmeyer also recently made the following trade(s):

  • On Thursday, June 29th, Gary S. Petersmeyer sold 100 shares of Cooper Companies, Inc. (The) stock. The shares were sold at an average price of $239.78, for a total transaction of $23,978.00.

Cooper Companies, Inc. (NYSE:COO) opened at 245.21 on Friday. The stock has a 50 day moving average price of $245.23 and a 200-day moving average price of $224.59. The firm has a market cap of $11.98 billion, a P/E ratio of 36.76 and a beta of 0.59. Cooper Companies, Inc. has a one year low of $158.73 and a one year high of $256.39.

Cooper Companies, Inc. (The) (NYSE:COO) last released its quarterly earnings data on Thursday, August 31st. The medical device company reported $2.64 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.58 by $0.06. Cooper Companies, Inc. (The) had a return on equity of 16.00% and a net margin of 16.45%. The business had revenue of $556.00 million for the quarter, compared to analysts’ expectations of $552.32 million. During the same quarter in the previous year, the business posted $2.30 EPS. Cooper Companies, Inc. (The)’s revenue for the quarter was up 8.0% on a year-over-year basis. Analysts predict that Cooper Companies, Inc. will post $9.72 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This report was originally reported by Daily Political and is owned by of Daily Political. If you are reading this report on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.dailypolitical.com/2017/09/17/insider-selling-cooper-companies-inc-the-coo-director-sells-974126-38-in-stock.html.

Large investors have recently added to or reduced their stakes in the company. Schwab Charles Investment Management Inc. lifted its holdings in shares of Cooper Companies, Inc. (The) by 5.6% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 244,686 shares of the medical device company’s stock valued at $58,583,000 after purchasing an additional 13,004 shares in the last quarter. Scout Investments Inc. lifted its holdings in shares of Cooper Companies, Inc. (The) by 29.3% during the 2nd quarter. Scout Investments Inc. now owns 116,320 shares of the medical device company’s stock valued at $27,849,000 after purchasing an additional 26,370 shares in the last quarter. Dai Ichi Life Insurance Company Ltd bought a new position in shares of Cooper Companies, Inc. (The) during the 1st quarter valued at about $206,000. Arizona State Retirement System lifted its holdings in shares of Cooper Companies, Inc. (The) by 0.5% during the 1st quarter. Arizona State Retirement System now owns 20,200 shares of the medical device company’s stock valued at $4,038,000 after purchasing an additional 100 shares in the last quarter. Finally, Columbia Partners L L C Investment Management bought a new position in shares of Cooper Companies, Inc. (The) during the 1st quarter valued at about $253,000. Institutional investors and hedge funds own 95.92% of the company’s stock.

COO has been the subject of a number of analyst reports. Robert W. Baird reaffirmed a “buy” rating and set a $273.00 price objective (up from $267.00) on shares of Cooper Companies, Inc. (The) in a research note on Tuesday, September 12th. Zacks Investment Research raised shares of Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $277.00 price objective for the company in a research note on Tuesday, August 29th. J P Morgan Chase & Co reaffirmed a “neutral” rating and set a $206.00 price objective (up from $200.00) on shares of Cooper Companies, Inc. (The) in a research note on Monday, June 5th. Jefferies Group LLC set a $250.00 price objective on shares of Cooper Companies, Inc. (The) and gave the company a “buy” rating in a research note on Thursday, August 17th. Finally, Oppenheimer Holdings, Inc. reaffirmed a “hold” rating and set a $250.00 price objective on shares of Cooper Companies, Inc. (The) in a research note on Tuesday, September 12th. Six equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $257.60.

Cooper Companies, Inc. (The) Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Insider Buying and Selling by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with MarketBeat.com's FREE daily email newsletter.